Hemas Pharmaceuticals, the leading pharmaceutical distributor in Sri Lanka has been recognized by Bureau Veritas as a Good Distribution Practices (GDP) organization, marking yet another milestone. GDP accreditation shows that Hemas Pharmaceuticals follows the World Health Organisation’s requirements for Good Distribution Practices of Pharmaceutical Products. Furthermore, this accreditation assures that quality management systems are consistent throughout the supply chain.
Commenting on the recognition, Jude Fernando, Managing Director – Hemas Pharmaceuticals and Hemas Surgicals & Diagnostics stated: “I strongly believe that with this latest addition of accomplishment, we can aim to address the diverse and sophisticated needs of all our partners as every procedure follows international quality standards established for receiving, storing, and distributing pharmaceuticals. As the number one Sri Lankan pharmaceutical importer and distributor, now we are honoured to serve our principals with both the accolades of ISO 9001:2015 and GDP certification from Bureau Veritas, which is globally recognized and clearly demonstrates the Hemas Pharmaceuticals commitment on compliance and quality”.
The Certification was presented to Mr. Jude Fernando, Managing Director- Hemas Pharmaceuticals by Mr. Shan Nanayakkara – Country General Manager – Bureau Veritas.